The consolidated results for the first quarter of the fiscal year ending March 2027 show net sales of 13,700 million yen (up 13.3% YoY), operating profit of 1,234 million yen (up 32.8% YoY), ordinary profit of 1,763 million yen (up 34.1% YoY), and net income attributable to owners of the parent of 1,137 million yen (up 27.0% YoY), marking a substantial earnings increase. The goodwill arising from the consolidation of the new subsidiary SANWA is included. Full-year guidance is expected to be revised.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6381","jir_company_name":"Anest Iwata Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/6381-20260810-01.pdf","jir_short_summary":"The consolidated results for the first quarter of the fiscal year ending March 2027 show net sales of 13,700 million yen (up 13.3% YoY), operating profit of 1,234 million yen (up 32.8% YoY), ordinary profit of 1,763 million yen (up 34.1% YoY), and net income attributable to owners of the parent of 1,137 million yen (up 27.0% YoY), marking a substantial earnings increase. The goodwill arising from the consolidation of the new subsidiary SANWA is included. Full-year guidance is expected to be revised.","jir_summary":"### Overview of Performance\nThe first quarter of this fiscal year posted a 13.3% increase in net sales vs. the prior year, with solid momentum across Japan, Asia, Europe, the Americas, and Greater China\/ASEAN as well. Goodwill was recorded due to the consolidation of the new subsidiary SANWA. Overall, there is an ongoing improvement in profitability.\n\n### Outlook and Considerations\nThe full-year earnings forecast for the FY ending March 2027 is expected to be revised. Potential impacts include geopolitical risks, supply chain dynamics, and contributions from the new subsidiary. An earnings briefing material will be prepared, but no investor briefing will be held.","jir_financial_highlights":"Net sales: 13,700\u767e\u4e07\u5186 (YoY +13.3%)\nOperating profit: 1,234\u767e\u4e07\u5186 (YoY +32.8%)\nOrdinary profit: 1,763\u767e\u4e07\u5186 (YoY +34.1%)\nNet income attributable to owners of the parent: 1,137\u767e\u4e07\u5186 (YoY +27.0%)","jir_category":"","jir_hashtags":"#AnestIwata, #Earnings, #BeginningOfTerm, #SANWAConsolidation","jir_key_figures":"Net sales: 13,700\u767e\u4e07\u5186\uff08YoY +13.3%\uff09\nOperating profit: 1,234\u767e\u4e07\u5186\uff08YoY +32.8%\uff09\nOrdinary profit: 1,763\u767e\u4e07\u5186\uff08YoY +34.1%\uff09","jir_meta_title":"Anest Iwata Q1 Results Released | Net Sales 13,700 million yen, Profit Rising","jir_meta_description":"Highlights of Anest Iwata's Q1 FY2027 results. Net sales 13,700 million yen, operating profit 1,234 million yen, ordinary profit 1,763 million yen, net income 1,137 million yen. Includes impact of SANWA subsidiary consolidation; potential revision to full-year guidance.","jir_og_title":"Anest Iwata Reports Q1 Results | Growth in Sales and Profits","jir_og_description":"Anest Iwata's Q1 FY2027 results show net sales of 13,700 million yen, operating profit 1,234 million yen, ordinary profit 1,763 million yen, and net income 1,137 million yen. Includes disclosure of SANWA consolidation impact.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17002,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-101119","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n